Affordable molecular detection platforms
and kits for Africans
Research
Diagnostic biomarker discovery
We are using next-gen high throughput methods to investigate and build Africa’s largest multi-omics database by screening communicable and non-communicable diseases prevalent in African communities for improved diagnostics biomarker discovery to power our precision diagnostic development algorithm.
AMR Diagnosis and Research
Using microBIS.io, our proprietary and novel platform, we are reimaging bacterial identification and Antimicrobial Resistance diagnosis using Artificial Intelligence, Machine Learning, and Software Engineering. This platform enables researchers, diagnostic scientists, and hospitals to digitize and generate insight into their AMR and identified bacteria datasets.
Molecular Diagnostics PoCT R&D
Using rich insights from our molecular and phenotypic database for biomarker discovery, we use next-gen technologies to build context-specific precision diagnostic tools and biosensor kits.
R&D projects
Who we are(About)
Precision medicine should not be a preserve for patients of the developed world. Implementing successful precision medicine programs in socially non-inclusive backgrounds requires cost-effective solutions. At the same time, for a doctor to recommend precision treatments, there is a need for personalized diagnostics tests that are locally and easily accessible.
That is where we come in; Duplex Bioscience, a Ghanaian biotech startup is developing affordable molecular detection platforms and kits for communicable and non-communicable diseases diagnosis and research in Africa. A paradigm that will spur better healthcare outcomes in Africa and beyond.
